MedTrace Logo

Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation

NCT02544906 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2015-09-09

No results posted yet for this study

Summary

The use of propofol or dexmedetomedine for prevention of sevofurane emergence agitation in LDLT recipients

Conditions

  • Liver Transplantation

Interventions

DRUG

Propofol

Infusion of propofol to prevent emergence agitation in liver transplanta recipients

DRUG

dexmedetomedine

Infusion of dexmedetomedine to prevent emergence agitation in liver transplanta recipients

Sponsors & Collaborators

  • AlRefaey Kandeel

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02544906 on ClinicalTrials.gov